DK2491021T3 - Nye acylpiperazinoner og deres anvendelse som lægemidler - Google Patents

Nye acylpiperazinoner og deres anvendelse som lægemidler

Info

Publication number
DK2491021T3
DK2491021T3 DK10768235.3T DK10768235T DK2491021T3 DK 2491021 T3 DK2491021 T3 DK 2491021T3 DK 10768235 T DK10768235 T DK 10768235T DK 2491021 T3 DK2491021 T3 DK 2491021T3
Authority
DK
Denmark
Prior art keywords
acylpiperazinones
medicines
new
new acylpiperazinones
Prior art date
Application number
DK10768235.3T
Other languages
English (en)
Inventor
Sonia Escaich
Mayalen Oxoby
Francois Moreau
Vincent Gerusz
Original Assignee
Fab Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fab Pharma Sas filed Critical Fab Pharma Sas
Application granted granted Critical
Publication of DK2491021T3 publication Critical patent/DK2491021T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK10768235.3T 2009-10-20 2010-10-20 Nye acylpiperazinoner og deres anvendelse som lægemidler DK2491021T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25335409P 2009-10-20 2009-10-20
PCT/EP2010/065811 WO2011048153A1 (en) 2009-10-20 2010-10-20 Novel acylpiperazinones and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
DK2491021T3 true DK2491021T3 (da) 2014-07-14

Family

ID=43334342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10768235.3T DK2491021T3 (da) 2009-10-20 2010-10-20 Nye acylpiperazinoner og deres anvendelse som lægemidler

Country Status (8)

Country Link
US (2) US8383621B2 (da)
EP (1) EP2491021B1 (da)
JP (1) JP5752138B2 (da)
CA (1) CA2774910A1 (da)
DK (1) DK2491021T3 (da)
ES (1) ES2483120T3 (da)
PL (1) PL2491021T3 (da)
WO (1) WO2011048153A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2774910A1 (en) 2009-10-20 2011-04-28 Vincent Gerusz Novel acylpiperazinones and their use as pharmaceuticals
CN116143782B (zh) * 2021-11-22 2024-04-12 西南大学 一类螺[吡咯烷-2,3'-喹啉]-2'-酮类衍生物的设计合成与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687547B2 (en) * 2004-08-23 2010-03-30 Research Foundation Of State University Of New York Diphenyl ether antimicrobial compounds
EP1845087A1 (en) * 2006-04-14 2007-10-17 Mutabilis SA Hydroxyphenyl derivatives and biological applications thereof
NZ598074A (en) * 2009-09-01 2014-04-30 Fab Pharma Sas Novel antibacterial hydroxyphenyl compound
CA2774910A1 (en) 2009-10-20 2011-04-28 Vincent Gerusz Novel acylpiperazinones and their use as pharmaceuticals

Also Published As

Publication number Publication date
ES2483120T3 (es) 2014-08-05
EP2491021A1 (en) 2012-08-29
JP2013508341A (ja) 2013-03-07
WO2011048153A1 (en) 2011-04-28
PL2491021T3 (pl) 2014-10-31
EP2491021B1 (en) 2014-04-23
US8383621B2 (en) 2013-02-26
JP5752138B2 (ja) 2015-07-22
US8623865B2 (en) 2014-01-07
US20130137689A1 (en) 2013-05-30
CA2774910A1 (en) 2011-04-28
US20120232079A1 (en) 2012-09-13

Similar Documents

Publication Publication Date Title
DK3608325T3 (da) Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse
SMT201700095B (is) Composizioni farmaceutiche per inalazione
BRPI1013639A2 (pt) medicamentos antidiabéticos
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
DK3597644T3 (da) Kationiske aminlipider og anvendelser deraf
DK2536722T3 (da) Bicycliske forbindelser og deres anvendelse som dual-c-src-/jak-inhibitorer
BR112012011902A2 (pt) cápsula farmacêutica
DK2479174T3 (da) 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI1014997A2 (pt) compostos heteroarila e usos dos mesmos
DK2421825T3 (da) Azetidinyldiamider som monoacylglycerollipase-inhibitorer
BRPI1004940A2 (pt) composição farmacêutica
SMT201400069B (it) Formulazione farmaceutica
DK2310501T3 (da) Nye regulatoriske elementer
BRPI1015939A2 (pt) composição farmacêutica
CO6801713A2 (es) Heteroarilos y sus usos
DK2120936T3 (da) Nye fremgangsmåder
DK2516330T3 (da) Partikelformigt titaniumdioxid
DK2234976T3 (da) Nye pyrazol-substituerede arylamider
DK2470499T3 (da) Nye colchicin-derivativer, fremgangsmåder og anvendelse deraf
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
DK2736888T3 (da) 3-heteroaroylaminopropionsyrederivater og deres anvendelse som farmaceutika
DK3392252T3 (da) Pyrimido-pyridazinonforbindelser og deres anvendelse
DK2809669T3 (da) Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika